These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16933358)

  • 21. Rational design of improved aziridine-based inhibitors of cysteine proteases.
    Buback V; Mladenovic M; Engels B; Schirmeister T
    J Phys Chem B; 2009 Apr; 113(15):5282-9. PubMed ID: 19301885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism.
    Vicik R; Helten H; Schirmeister T; Engels B
    ChemMedChem; 2006 Sep; 1(9):1021-8. PubMed ID: 16933238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.
    Yamashita DS; Dong X; Oh HJ; Brook CS; Tomaszek TA; Szewczuk L; Tew DG; Veber DF
    J Comb Chem; 1999; 1(3):207-15. PubMed ID: 10746010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
    Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
    Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
    J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.
    Shah PP; Myers MC; Beavers MP; Purvis JE; Jing H; Grieser HJ; Sharlow ER; Napper AD; Huryn DM; Cooperman BS; Smith AB; Diamond SL
    Mol Pharmacol; 2008 Jul; 74(1):34-41. PubMed ID: 18403718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.
    Yadav MR; Shinde AK; Chouhan BS; Giridhar R; Menard R
    J Enzyme Inhib Med Chem; 2008 Apr; 23(2):190-7. PubMed ID: 18343903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin L is an intracellular and extracellular protease in Paramecium tetraurelia. Purification, cloning, sequencing and specific inhibition by its expressed propeptide.
    Völkel H; Kurz U; Linder J; Klumpp S; Gnau V; Jung G; Schultz JE
    Eur J Biochem; 1996 May; 238(1):198-206. PubMed ID: 8665938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
    Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
    Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.
    Ettari R; Nizi E; Di Francesco ME; Dude MA; Pradel G; Vicík R; Schirmeister T; Micale N; Grasso S; Zappalà M
    J Med Chem; 2008 Feb; 51(4):988-96. PubMed ID: 18232656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cathepsin X. A novel cysteine protease with unique specificity.
    Ménard R; Nägler DK; Zhang R; Tam W; Sulea T; Purisima EO
    Adv Exp Med Biol; 2000; 477():317-22. PubMed ID: 10849759
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
    Löser R; Schilling K; Dimmig E; Gütschow M
    J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.
    Setti EL; Davis D; Janc JW; Jeffery DA; Cheung H; Yu W
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1529-34. PubMed ID: 15713422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bombyx cysteine proteinase inhibitor (BCPI) homologous to propeptide regions of cysteine proteinases is a strong, selective inhibitor of cathepsin L-like cysteine proteinases.
    Kurata M; Yamamoto Y; Watabe S; Makino Y; Ogawa K; Takahashi SY
    J Biochem; 2001 Dec; 130(6):857-63. PubMed ID: 11726287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
    Ljunggren A; Redzynia I; Alvarez-Fernandez M; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
    J Mol Biol; 2007 Aug; 371(1):137-53. PubMed ID: 17561110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.